Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Saad H. S. Albohairi"'
Autor:
Mamdooh Gari, Abdulrahman L. Al-Malki, Farid Ahmed, Asad Muhammad Ilyas, Mohammed H. Al-Qahtani, Khalid Omer Abualnaja, Youssri M. Ahmed, Adeel G. Chaudhary, Saad H. S. Albohairi, Taha A. Kumosani
Publikováno v:
Open Journal of Blood Diseases. :9-16
Sunitinib is an orally administered, multi-target tyrosine kinase inhibitor that has been approved by the FDA for the treatment of renal cell carcinoma and imatinib resistant gastro-intestinal tumors. Anti-leukemic activity of sunitinib has been exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a1df8c8730cb9ead29a9a59d94287f3
https://doi.org/10.4236/ojbd.2016.61003
https://doi.org/10.4236/ojbd.2016.61003
